ABSTRACT
Desde o começo de sua comercialização, em 1996, a área global de plantações transgênicas aumentou mais de cinquenta vezes. Nas duas últimas décadas, organizações governamentais e intergovernamentais têm planejado estratégias e protocolos para o estudo da segurança de alimentos derivados de cultivos geneticamente modificados. Os testes de segurança são realizados caso a caso e conduzidos de acordo com as características específicas das culturas modificadas e as mudanças introduzidas através da modificação genética, levando em conta o conceito de equivalência substancial. No presente trabalho, estão relatadas algumas abordagens de avaliação de risco de alimentos geneticamente modificados, assim como alguns problemas relacionados à construção genética ou mesmo à expressão do gene inserido.
Since the commercial approve in 1996, the global area of transgenic crops has raised more than 50 times. In the last two decades, governments have been planning strategies and protocols for safety assessment of food and feed genetically modified (GM). Evaluation of food safety should be taken on a case-by-case analysis depending on the specific traits of the modified crops and the changes introduced by the genetic modification, using for this the concept of substantial equivalence. This work presents approaches for the risk assessment of GM food, as well as some problems related with the genetic construction or even with the expression of the inserted gene.
Subject(s)
Humans , Food Safety , Plants, Genetically Modified , Brazil , Risk AssessmentABSTRACT
The enterococci are important nosocomial pathogens with a remarkable capacity of expressing resistance to several antimicrobial agents. Their ubiquitous nature and resistance to adverse environmental conditions take account for their ability to colonize different habitats and for their potential for easy spreading through the food chain. In the present study we evaluated the distribution of species and antimicrobial susceptibility among enterococcal isolates recovered from food obtained in retail stores in Rio de Janeiro, Brazil. The following species were identified among 167 isolates obtained from poultry meat and 127 from pasteurized milk: Enterococcus faecalis (62.6 percent), E. casseliflavus (17.3 percent), E. durans (6.5 percent), E. gallinarum (3.0 percent), E. gilvus (2.4 percent), E. faecium (2.0 percent), E. hirae (1.4 percent), and E. sulfureus (1.0 percent). The overall percentages of antimicrobial resistant isolates were: 31.2 percent to tetracycline, 23.8 percent to erythromycin, 11.3 percent to streptomycin, 4.3 percent to chloramphenicol, 3.9 percent to gentamicin, 1.4 percent to norfloxacin, 1.1 percent to imipenem, 0.7 percent to ciprofloxacin, nitrofurantoin, and penicillin, and 0.4 percent to ampicillin. Intermediate resistance was detected in frequencies varying from 0.5 percent for linezolid to 58.2 percent for erythromycin. None of the isolates showed resistance to glycopeptides. High-level resistance to aminoglycosides was observed in 13.1 percent of the isolates. Multiresistance was observed in E. faecalis, E. casseliflavus, E. faecium, E. gallinarum, E. durans and E. gilvus.